MiniMed (MMED) EBITDA (2025 - 2026)
MiniMed (MMED) posted EBITDA of -$93.0 million for Q2 2026, up 7.0% on a QoQ basis from -$100.0 million in Q1 2026, and up 37.16% year-over-year from -$67.8 million in Q2 2025.
MiniMed (MMED) EBITDA (2025 - 2026) Analysis & Trends
MiniMed's EBITDA history runs 2 years deep, the most recent figure standing at -$93.0 million for Q2 2026.
- Quarterly EBITDA rose 37.16% year-over-year to -$93.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$320.0 million (changed N/A YoY) and the FY2026 annual result came in at -$190.0 million, down 30.14% from the prior year.
- EBITDA was -$93.0 million for Q2 2026 at MiniMed, up from -$100.0 million in the prior quarter.
- Across five years, EBITDA topped out at $21.0 million in Q1 2025 and bottomed at -$148.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 273.11 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 121.45 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 102.95 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | -17.05 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 32.07 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | -93.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 80.47 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 24.83 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 7.42 Mn |
| 10 | Omnicell | 1.81 Bn | 1.57 Bn | 140.36 Mn | 16.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | -93.00 Mn |
| Jan 23, 2026 | -100.00 Mn |
| Apr 25, 2025 | -148.00 Mn |
| Jan 24, 2025 | 21.00 Mn |